Posted by John Deo
Earnings Per Share (EPS) of $0.57, surpassing estimates and indicating a 21.28% earnings surprise despite a s
Source: Two Blokes Trading
Posted by John Deo
JD.com Inc (NASDAQ:JD) is set to release its quarterly earnings on March 6, 2025, with an estimated EPS of $0
Source: Two Blokes Trading
Posted by John Deo
Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical company focused on developing therapies for patients
Source: Two Blokes Trading
Posted by John Deo
Informatica Inc. (NYSE:INFA) has a Return on Invested Capital (ROIC) of 0.58%, significantly lower than its W
Source: Two Blokes Trading
Posted by John Deo
GTES's ROIC to WACC ratio of 0.43 indicates inefficiency in capital utilization compared to its peers. JELD-W
Source: Two Blokes Trading
Posted by John Deo
Director BEST RHYS J's purchase of 1,500 shares at $79.84 each reflects confidence in Arcosa's future. Arcosa
Source: Two Blokes Trading
Posted by John Deo
Wall Street analysts estimate an earnings per share of $0.32 and projected revenue of $12.45 million for the
Source: Two Blokes Trading
Posted by John Deo
KT Corporation reported an EPS of -0.88, beating estimates. The company's revenue was $4.54 billion, sli
Source: Two Blokes Trading
Posted by John Deo
Endeavour Mining PLC (PNK:EDVMF) maintains a strong position in the gold mining industry with efficient produ
Source: Two Blokes Trading
Posted by John Deo
Hologic's ROIC of 10.04% surpasses its WACC of 7.88%, indicating efficient capital utilization and value crea
Source: Two Blokes Trading
Posted by John Deo
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) is a pharmaceutical company focused on the discovery and developmen
Source: Two Blokes Trading
Posted by John Deo
Evogene Ltd. (NASDAQ:EVGN) is set to release its quarterly earnings with an estimated EPS of -$0.725 and proj
Source: Two Blokes Trading